Search Clinical Trials

The purpose of this trial is to evaluate the efficacy and safety of riluzole in the treatment of patients with acute SCI.

Investigator: Shekar N. Kurpad, MD, PhD

Status: Currently enrolling

Keywords
TBI, Exception from Informed Consent

The research studies blood flow in aneurysm for the selection of treatment. (NIH RO1: HL115267)

The database is designed specifically to serve as a screening and recruitment tool for stroke researchers in the greater Milwaukee Area, matching stroke survivors willing to contribute to science as research participants with study coordinators seeking to populate their studies with individuals meeting their particular inclusion/exclusion criteria.

This is a randomized, double-blind, placebo-controlled trial of urate-elevating inosine treatment to slow clinical decline in early Parkinson’s disease.

This is a randomized, double-blind, placebo-controlled, phase IIa, parallel-group, two-cohort study to define the safety, tolerability, clinical and exploratory biological activity of the chronic administration of Nilotinib in participants with Parkinson’s disease (PD).

Keywords
Parkinson’s Disease, PD, Nilotinib

The purpose of this study is to understand what gene mutations can contribute to ALS. Understanding the gene mutations could lead to insight into future therapies.

Keywords
Amyotrophic Lateral Sclerosis, ALS, gene mutations, genetic

The purpose of this study is to test what changes happen in participants with ALS that can be seen in the blood and urine and what changes are unique to ALS. These changes are called biomarkers.

Keywords
Amyotrophic Lateral Sclerosis, ALS, Primary Lateral Sclerosis, PLS, Progressive Muscular Atrophy, PMA, Motor Neuron Disease, Biomarker

This randomized, double-blind, controlled, parallel group study evaluates the efficacy and safety of FLX-787-ODT for treatment of muscle cramps in adult subjects with motor neuron disease.

Keywords
Motor Neuron Disease, Muscle cramps, FLX-787-OD

This is a phase 2, multicenter, double-blind, randomized, dose-ranging, placebo-controlled study to evaluate the efficacy, safety and tolerability of CK-2127107 in patients with amyotrophic lateral sclerosis (ALS).

Keywords
Amyotrophic Lateral Sclerosis, ALS, CK-2127107

This is a multicenter, double-blind, placebo-controlled study to assess the efficacy and safety of H.P. Acthar® Gel in the treatment of subjects with amyotrophic lateral sclerosis (ALS). MNK14042068

Keywords
Amyotrophic Lateral Sclerosis, ALS, Acthar

Keywords
Low back pain, degenerative disc disease, healthy volunteers

Keyword
Spinal Cord Injury
 

Keyword
Cervical surgery

Keyword
Brain Tissue Bank